Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Fassas

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transferPanayotis Kaloyannidis, Ioannis Batsis, Evangelia Yannaki, et al.
British Journal of Haematology|July 25, 2003
MDS-type abnormalities within myeloma signature karyotype (MM-MDS): only 13% 1-year survival despite tandem transplantsJoth Jacobson, Bart Barlogie, John Shaughnessy, et al.
Experimental Hematology|October 19, 2006
Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cellsEvangelia Yannaki, Achilles Anagnostopoulos, Demetrios Kapetanos, et al.
Molecular Medicine (Cambridge, Mass.)|April 20, 2006
Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemiaChrysoula Belessi, Kostas Stamatopoulos, Anastasia Hadzidimitriou, et al.
Leukemia Research|August 19, 2003
Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemiaPanagoula Kollia, Maria Samara, Kostas Stamatopoulos, et al.
Haematologica|June 14, 2006
Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 casesAnastasia Hadzidimitriou, Kostas Stamatopoulos, Chrysoula Belessi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioningAshraf Badros, Bart Barlogie, Eric Siegel, et al.
British Journal of Haematology|February 14, 2002
Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplantsGuido Tricot, Trey Spencer, Jeffrey Sawyer, et al.
British Journal of Haematology|December 21, 2002
Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy IIJohn Shaughnessy, Erming Tian, Jeffrey Sawyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myelomaChoon-Kee Lee, Bart Barlogie, Nikhil Munshi, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transferPanayotis Kaloyannidis, Ioannis Batsis, Evangelia Yannaki, et al.
British Journal of Haematology|July 25, 2003
MDS-type abnormalities within myeloma signature karyotype (MM-MDS): only 13% 1-year survival despite tandem transplantsJoth Jacobson, Bart Barlogie, John Shaughnessy, et al.
Experimental Hematology|October 19, 2006
Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cellsEvangelia Yannaki, Achilles Anagnostopoulos, Demetrios Kapetanos, et al.
Molecular Medicine (Cambridge, Mass.)|April 20, 2006
Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemiaChrysoula Belessi, Kostas Stamatopoulos, Anastasia Hadzidimitriou, et al.
Leukemia Research|August 19, 2003
Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemiaPanagoula Kollia, Maria Samara, Kostas Stamatopoulos, et al.
Haematologica|June 14, 2006
Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 casesAnastasia Hadzidimitriou, Kostas Stamatopoulos, Chrysoula Belessi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioningAshraf Badros, Bart Barlogie, Eric Siegel, et al.
British Journal of Haematology|February 14, 2002
Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplantsGuido Tricot, Trey Spencer, Jeffrey Sawyer, et al.
British Journal of Haematology|December 21, 2002
Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy IIJohn Shaughnessy, Erming Tian, Jeffrey Sawyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myelomaChoon-Kee Lee, Bart Barlogie, Nikhil Munshi, et al.
Pageof 6